| MicroRNA–mRNA interactions in colorectal cancer and their role in tumor progression R Amirkhah, U Schmitz, M Linnebacher, O Wolkenhauer, A Farazmand Genes, Chromosomes and Cancer 54 (3), 129-141, 2015 | 94 | 2015 |
| Exosomal lncRNAs and cancer: connecting the missing links H Naderi-Meshkin, X Lai, R Amirkhah, J Vera, JEJ Rasko, U Schmitz Bioinformatics 35 (2), 352-360, 2019 | 62 | 2019 |
| Cancer statistics in Iran: Towards finding priority for prevention and treatment R Amirkhah, H Naderi-Meshkin, M Mirahmadi, A Allahyari, HR Sharifi cancerpress, 2017 | 59 | 2017 |
| The intricate interplay between epigenetic events, alternative splicing and noncoding RNA deregulation in colorectal cancer R Amirkhah, H Naderi-Meshkin, JS Shah, PD Dunne, U Schmitz Cells 8 (8), 929, 2019 | 39 | 2019 |
| Naïve Bayes classifier predicts functional microRNA target interactions in colorectal cancer R Amirkhah, A Farazmand, SK Gupta, H Ahmadi, O Wolkenhauer, ... Molecular bioSystems 11 (8), 2126-2134, 2015 | 32 | 2015 |
| The role of microRNAs in the resistance to colorectal cancer treatments R Amirkhah, A Farazmand, M Irfan-Maqsood, O Wolkenhauer, U Schmitz Cellular and Molecular Biology 61 (6), 17-23, 2015 | 27 | 2015 |
| Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data NC Fisher, R Byrne, H Leslie, C Wood, A Legrini, A Cameron, ... Clin Cancer Res, 4056-4069, 2022 | 23 | 2022 |
| In-depth clinical and biological exploration of DNA damage immune response as a biomarker for oxaliplatin use in colorectal cancer SB Malla, DJ Fisher, E Domingo, A Blake, S Hassanieh, KL Redmond, ... Clinical Cancer Research 27 (1), 288-300, 2021 | 22 | 2021 |
| Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer SB Malla, RM Byrne, MW Lafarge, SM Corry, NC Fisher, PK Tsantoulis, ... Nature genetics 56 (3), 458-472, 2024 | 18 | 2024 |
| MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer R Amirkhah, K Gilroy, SB Malla, TRM Lannagan, RM Byrne, NC Fisher, ... British Journal of Cancer 128 (7), 1333-1343, 2023 | 15 | 2023 |
| Activation of innate-adaptive immune machinery by poly (I: C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer SM Corry, AMB McCorry, TRM Lannagan, NA Leonard, NC Fisher, ... Gut 71 (12), 2502-2517, 2022 | 11 | 2022 |
| Downregulation of PPARα during experimental left ventricular hypertrophy is critically dependent on Nox2 NADPH oxidase signalling AP Harvey, E Robinson, KS Edgar, R McMullan, KM O’Neill, M Alderdice, ... International journal of molecular sciences 21 (12), 4406, 2020 | 11 | 2020 |
| Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data B Ahmaderaghi, R Amirkhah, J Jackson, TRM Lannagan, K Gilroy, ... Disease Models & Mechanisms 15 (3), dmm049257, 2022 | 8 | 2022 |
| Critical issues in successful production of skin substitutes for wound healing H Naderi-Meshkin, R Amirkhah, A Heirani-Tabasi, MI Maqsood Journal of Genes and Cells 4 (1), 10-32, 2018 | 8 | 2018 |
| Computational and experimental identification of Tissue-Specific MicroRNA targets R Amirkhah, HN Meshkin, A Farazmand, JEJ Rasko, U Schmitz MicroRNA Detection and Target Identification: Methods and Protocols, 127-147, 2017 | 8 | 2017 |
| Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features DJ Flanagan, R Amirkhah, DF Vincent, N Gunduz, P Gentaz, ... Nature Communications 13 (1), 7551, 2022 | 7 | 2022 |
| Engineered Cell Therapy: A Successful Approach to Treat Cancer M Irfan-maqsood, M Bahrami, R Amirkhah, H Naderi-meshkin Genes and Cells 1, 1.82, 2015 | 3 | 2015 |
| Improvement of bladder cancer immunotherapy by creating a recombinant Bacille Calmette-Gu'erin which secrets p53 protein. R Amirkhah, H Khanahmad, M Abolhassani, M Pooya, H Movassagh, ... Medical hypotheses 72 (6), 754-754, 2009 | 3 | 2009 |
| Adoptive Cell Transfer to Enhance Patients Immunity Against Cancer M Irfan-Maqsood, M Bahrami, R Amirkhah Journal of Genes and Cells 1 (3), 67, 2015 | 2 | 2015 |
| Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer SB Malla, RM Byrne, MW Lafarge, SM Corry, NC Fisher, PK Tsantoulis, ... Nature Genetics, 1-1, 2024 | 1 | 2024 |
Hojjat Naderi-MeshkinQueen's University Belfast, UKDirección de correo verificada de qub.ac.uk
